Rezultati

eNauka >  Results >  Patient-reported outcomes (PROs) from KATHERINE: A phase III study of adjuvant trastuzumab emtansine (T-DM1) versus trastuzumab (H) in patients (pts) with residual invasive disease after neoadjuvant therapy for HER2-positive breast cancer.
Title: Patient-reported outcomes (PROs) from KATHERINE: A phase III study of adjuvant trastuzumab emtansine (T-DM1) versus trastuzumab (H) in patients (pts) with residual invasive disease after neoadjuvant therapy for HER2-positive breast cancer.
Authors : Schneeweiss, Andreas; ...; Stamatovic, Ljiljana; ...; (broj, koautora 20)
Issue Date: 2019
Publication: JOURNAL OF CLINICAL ONCOLOGY
ISSN: 0732-183X Journal of Clinical Oncology Search Idenfier
Type: Conference Paper
Collation: vol. 37 br. 15 str. 513-513
DOI: 10.1200/JCO.2019.37.15_suppl.513
WoS-ID: 000487345803506
URI: https://enauka.gov.rs/handle/123456789/815546
Metadata source: (Preuzeto iz Nasi u WoS)
M-category: 
Mp. category will be shown later

1
OpenCitations
2
WEB OF SCIENCETM
Alt metrika
Dimensions
Unpaywall

Google ScholarTM

Rezultati na eNauka su zaštićeni autorskim pravima i sva prava su zadržana, osim ako nije drugačije naznačeno.